Diagnostic Immunohistochemistry 2006
DOI: 10.1016/b978-0-443-06652-8.50018-1
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistology of Skin Tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2008
2008
2014
2014

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 297 publications
0
5
0
Order By: Relevance
“…Apocrine nevus can be distinguished from tubular apocrine adenoma with the latter having anastomosing tubular structures, frequent luminal papillations, and a more fibrotic stroma. 4 S100 positivity is seen more often in eccrine-derived lesions rather than apocrine-derived lesions, 15 whereas EMA positivity is more common in malignancies of apocrine and eccrine derivation. Sudoriferous tumors are typically positive for cytokeratin, carcinoembryonic antigen (CEA), CA72.4, CD15, and p63.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Apocrine nevus can be distinguished from tubular apocrine adenoma with the latter having anastomosing tubular structures, frequent luminal papillations, and a more fibrotic stroma. 4 S100 positivity is seen more often in eccrine-derived lesions rather than apocrine-derived lesions, 15 whereas EMA positivity is more common in malignancies of apocrine and eccrine derivation. Sudoriferous tumors are typically positive for cytokeratin, carcinoembryonic antigen (CEA), CA72.4, CD15, and p63.…”
Section: Discussionmentioning
confidence: 99%
“…15 Both apocrine and eccrine glands contain and secrete CEA. Apocrine nevus can be distinguished from tubular apocrine adenoma with the latter having anastomosing tubular structures, frequent luminal papillations, and a more fibrotic stroma.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Considering the patient's findings on imaging, additional differential diagnoses include metastatic urothelial carcinoma and other metastatic malignancies of gynecologic origin. Immunohistochemical markers such as cytokeratin 5/6, p40, and p63 may be used at the pathologists' discretion to confirm that the tumor is truly of squamous origin, and to rule out metastatic carcinomas from different sites [20,21] . In this case, given the patient's clinical history and presentation, a diagnosis of cutaneous metastases from the patient's primary cervical squamous cell carcinoma was favored.…”
Section: Discussionmentioning
confidence: 99%
“…The sensitivity and specificity of several immunological stains that may be used in the diagnosis of KS is shown in Table 1. Most vascular conditions are likely to be immunoreactive for the endothelial markers factor VIII‐related antigen, CD31 and CD34 11 . Thrombomodulin and UEA‐1 are not widely used in contemporary surgical pathology practice as specific endothelial markers.…”
Section: Usefulness Of Immunohistochemistrymentioning
confidence: 99%